We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amgen Inc. (AMGN - Free Report) , discovers, develops and delivers innovative human therapeutics. Shares of this Zacks #1, Strong Buy,have risen this year so far, compared with a decline for its industry. Acquisitions and Deals to drive growth and boost its pipeline. Amgen has several interesting candidates in its pipeline, which represent a significant commercial potential. The company boasts a strong biosimilars pipeline, which could be an important long-term growth driver for it.
Alibaba Group Holding Limited (BABA - Free Report) , operates online and mobile marketplaces in retail and wholesale trade, as well as cloud computing and other services. Alibaba reported strong fiscal first-quarter earnings driven by steady improvement in core commerce and cloud businesses, along with strong growth in metrics. Its strong momentum in both domestic as well as international market remains growth drivers. Further, Alibaba’s strengthening cloud business with its expanding customer base continues to drive its performance. Its New Retail strategy is also gaining momentum in the market. And, Alibaba continues to witness increasing monetization rates.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention. See them now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Top Stock Picks for Week of September 16, 2019
Amgen Inc. (AMGN - Free Report) , discovers, develops and delivers innovative human therapeutics. Shares of this Zacks #1, Strong Buy,have risen this year so far, compared with a decline for its industry. Acquisitions and Deals to drive growth and boost its pipeline. Amgen has several interesting candidates in its pipeline, which represent a significant commercial potential. The company boasts a strong biosimilars pipeline, which could be an important long-term growth driver for it.
Alibaba Group Holding Limited (BABA - Free Report) , operates online and mobile marketplaces in retail and wholesale trade, as well as cloud computing and other services. Alibaba reported strong fiscal first-quarter earnings driven by steady improvement in core commerce and cloud businesses, along with strong growth in metrics. Its strong momentum in both domestic as well as international market remains growth drivers. Further, Alibaba’s strengthening cloud business with its expanding customer base continues to drive its performance. Its New Retail strategy is also gaining momentum in the market. And, Alibaba continues to witness increasing monetization rates.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.
See them now >>